Clinical trial
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic…
NCT00439179 · Brown University, Other · Completed
Key facts
| NCT number | NCT00439179 |
|---|---|
| Title | A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema |
| Official title | BrUOG-PA-205 A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema GSK Study ProtocolGSK #103556 |
| Acronym | BrUOG-PA205 |
| Lead sponsor | Brown University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Metastatic Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | cohort 1, cohort 2, cohort 3, cohort 4 |
| Enrollment | 27 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 23, 2007 |
| Last update posted | Feb 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: